1,224
Views
30
CrossRef citations to date
0
Altmetric
Research Paper

Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia

, , &
Pages 957-965 | Received 11 Jul 2011, Accepted 18 Sep 2011, Published online: 01 Dec 2011

References

  • Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010; 29:154 - 9; http://dx.doi.org/10.1016/j.clnu.2009.12.004; PMID: 20060626
  • Argilés JM, Almendro V, Busquets S, Lopez-Soriano FJ. The pharmacological treatment of cachexia. Curr Drug Targets 2004; 5:265 - 77; http://dx.doi.org/10.2174/1389450043490505; PMID: 15058312
  • Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69:491 - 7; http://dx.doi.org/10.1016/S0149-2918(05)80001-3; PMID: 7424938
  • Warren S. The immediate causes of death in cancer. Am J Med Sci 1932; 184:610 - 5; http://dx.doi.org/10.1097/00000441-193211000-00002
  • Inagaki J, Rodriguez V, Bodey GP. Causes of death in cancer patients. Cancer 1974; 33:568 - 73; http://dx.doi.org/10.1002/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2; PMID: 4591273
  • Argilés JM. López-Soriano, Busquets S. Novel approaches to the treatment of cachexia. Drug Discov Today 2008; 13:73 - 8; http://dx.doi.org/10.1016/j.drudis.2007.10.008; PMID: 18190867
  • Bozzetti F, Ammatuna M, Migliavacca S, Bonalumi MG, Facchetti G, Pupa A, et al. Total parenteral nutrition prevents further nutritional deterioration in patients with cancer cachexia. Ann Surg 1987; 205:138 - 43; http://dx.doi.org/10.1097/00000658-198702000-00007; PMID: 3101624
  • Rohdenburg GL, Bernhard A, Krehbiel O. Sugar tolerance in cancer. J Am Med Assoc 1919; 72:528 - 30
  • Moley JF, Morrison SD, Norton JA. Preoperative insulin reverses cachexia and decreases mortality in tumor-bearing rats. J Surg Res 1987; 43:21 - 8; http://dx.doi.org/10.1016/0022-4804(87)90042-4; PMID: 3599982
  • Moley JF, Morrison SD, Gorschboth CM, Norton JA. Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin. Cancer Res 1988; 48:2784 - 7; PMID: 3282649
  • Peacock JL, Norton JA. Impact of insulin on survival of cachectic tumor bearing rats. JPEN J Parenter Enteral Nutr 1988; 12:260 - 4; http://dx.doi.org/10.1177/0148607188012003260; PMID: 3392822
  • Beck SA, Tisdale MJ. Effect of insulin on weight loss and tumour growth in a cachexia model. Br J Cancer 1989; 59:677 - 81; http://dx.doi.org/10.1038/bjc.1989.140; PMID: 2736199
  • Pearlstone DB, Wolf RF, Berman RS, Burt M, Brennan MF. Effect of systemic insulin on protein kinetics in postoperative cancer patients. Ann Surg Oncol 1994; 1:321 - 32; http://dx.doi.org/10.1007/BF02303571; PMID: 7850531
  • Lundholm K, Körner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, et al. Insulin treatment in cancer cachexia: effects on survival, metabolism and physical functioning. Clin Cancer Res 2007; 13:2699 - 706; http://dx.doi.org/10.1158/1078-0432.CCR-06-2720; PMID: 17473202
  • Cersosimo E, Pisters PW, Pesola G, Rogatko A, Vydelingum NA, Bajorunas D, et al. The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia. Surgery 1991; 109:459 - 67; PMID: 2008651
  • Dodesini AR, Benedini S, Terruzzi I, Sereni LP, Luzi L. Protein, glucose and lipid metabolism in the cancer cachexia: A preliminary report. Acta Oncol 2007; 46:118 - 20; http://dx.doi.org/10.1080/02841860600791491; PMID: 17438714
  • Asp ML, Tian M, Wendel AA, Belury MA. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer 2010; 126:756 - 63; http://dx.doi.org/10.1002/ijc.24784; PMID: 19634137
  • Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008; 118:2992 - 3002; http://dx.doi.org/10.1172/JCI34260; PMID: 18769626
  • Hauner H. The mode of action of thiazolidinediones. Diabetes Metab Res Rev 2002; 18:S10 - 5; http://dx.doi.org/10.1002/dmrr.249; PMID: 11921433
  • Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009; 89:381 - 410; http://dx.doi.org/10.1152/physrev.00016.2008; PMID: 19342610
  • Wang X, Hu Z, Hu J, Du J, Mitch WE. Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 2006; 147:4160 - 8; http://dx.doi.org/10.1210/en.2006-0251; PMID: 16777975
  • Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008; 27:793 - 9; http://dx.doi.org/10.1016/j.clnu.2008.06.013; PMID: 18718696
  • Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001; 98:14440 - 5; http://dx.doi.org/10.1073/pnas.251541198; PMID: 11717410
  • Bodine SC, Latres E, Baumhueter S, Lai VKM, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704 - 8; http://dx.doi.org/10.1126/science.1065874; PMID: 11679633
  • Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007; 6:458 - 71; http://dx.doi.org/10.1016/j.cmet.2007.11.001; PMID: 18054315
  • Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992; 89:1681 - 4; http://dx.doi.org/10.1172/JCI115767; PMID: 1569207
  • de Lange P, Moreno M, Silvestri E, Lombardi A, Goglia F, Lanni A. Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms. FASEB J 2007; 21:3431 - 41; http://dx.doi.org/10.1096/fj.07-8527rev; PMID: 17595346
  • Pecqueur C, Bui T, Gelly C, Hauchard J, Barbot C, Bouillaud F, et al. Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization. FASEB J 2008; 22:9 - 18; http://dx.doi.org/10.1096/fj.07-8945com; PMID: 17855623
  • Tian M, Kliewer KL, Asp ML, Sout MB, Belury MA. c9t11-Conjugated linoleic acid-rich oil fails to attenuate wasting in colon-26 tumor-induced late-stage cancer cachexia in male CD2F1 mice. Mol Nutr Food Res 2011; 55:268 - 77; http://dx.doi.org/10.1002/mnfr.201000176; PMID: 20827675
  • Lehrke M, Lazar MA. The many faces of PPARgamma. Cell 2005; 123:993 - 9; http://dx.doi.org/10.1016/j.cell.2005.11.026; PMID: 16360030
  • Guerre-Millo M. Adiponectin: an update. Diabetes Metab 2008; 34:12 - 8; PMID: 18069030
  • Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004; 114:370 - 8; PMID: 15286803
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25:402 - 8; http://dx.doi.org/10.1006/meth.2001.1262; PMID: 11846609

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.